Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Prostate Specific Antigen Antikörper (AA 247-261)

PSA Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN289484

Datenblatt (PDF)

Target Alle Prostate Specific Antigen (PSA) Antikörper anzeigen

Prostate Specific Antigen (PSA)
Bindungsspezifität
16

7

7

6

5

5

5

5

3

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 247-261
Reaktivität
166

10

5

4

1

1
Human
Wirt
93

66

4

3

2
Kaninchen
Passende Sekundärantikörper
Klonalität
106

63
Polyklonal
Konjugat
106

13

11

6

5

4

3

3

3

3

3

3

1

1

1

1

1

1

1
Dieser Prostate Specific Antigen Antikörper ist unkonjugiert
Applikation
76

64

39

31

25

24

13

12

11

10

8

8

5

4

3

3

2

2

2

2

2

2

2

1

1

1

1

1

1

1
Western Blotting (WB)

Aufreinigung

Affinity chromatography purified

Immunogen

KLK3 antibody was raised in rabbit using AA 247-261 [VHYRKWIKDTIVANP] of the human KLK3 protein as the immunogen.

Isotyp

IgG

Top Product

Discover our top product PSA Primärantikörper
anti-Prostate Specific Antigen (PSA) antibody
PSA Reaktivität: Human ELISA, WB, FACS, DB Wirt: Maus Monoclonal A5D5-1 unconjugated

anti-Prostate Specific Antigen (PSA) (AA 26-251) antibody
PSA Reaktivität: Human ELISA, WB, IHC, FACS Wirt: Maus Monoclonal 5A11E9 unconjugated

anti-Prostate Specific Antigen (PSA) (AA 1-100) antibody
PSA Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated

anti-Prostate Specific Antigen (PSA) antibody
PSA Reaktivität: Human ELISA, WB, IHC (p) Wirt: Maus Monoclonal A67-B-E3 unconjugated

anti-Prostate Specific Antigen (PSA) (AA 39-261) antibody
PSA Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Prostate Specific Antigen (PSA) antibody
PSA Reaktivität: Human IHC, StM, ISt Wirt: Kaninchen Monoclonal KLK3-2871R unconjugated Recombinant Antibody

anti-Prostate Specific Antigen (PSA) antibody
PSA Reaktivität: Human WB, IHC, IHC (p), FACS, ICC, IHC (fro), ELISpot Wirt: Maus Monoclonal C3F12 unconjugated

anti-Prostate Specific Antigen (PSA) (AA 150-250) antibody
PSA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-603R unconjugated Recombinant Antibody

anti-Prostate Specific Antigen (PSA) antibody (Biotin)
PSA Reaktivität: Human ELISA, WB, IHC (p) Wirt: Maus Monoclonal A67-B-E3 Biotin

anti-Prostate Specific Antigen (PSA) (AA 709-737), (C-Term) antibody
PSA Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB19102 unconjugated

Applikationshinweise

WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Konzentration

Lot specific

Buffer

Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung

Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung

4 °C/-20 °C

Informationen zur Lagerung

Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Target

Prostate Specific Antigen (PSA)

Andere Bezeichnung

KLK3 (PSA Produkte)

Synonyme

APS antikoerper, KLK2A1 antikoerper, PSA antikoerper, hK3 antikoerper, KLK3 antikoerper, Klk1c10l2 antikoerper, RSGK-50 antikoerper, RSKG-50 antikoerper, rGK-3 antikoerper, Kal-3 antikoerper, Kal3 antikoerper, Klk3 antikoerper, AAP-S antikoerper, MP100 antikoerper, Psa antikoerper, R74825 antikoerper, goku antikoerper, kallikrein related peptidase 3 antikoerper, kallikrein 3 antikoerper, kallikrein 1-related peptidase C3 antikoerper, kallikrein B, plasma 1 antikoerper, aminopeptidase puromycin sensitive antikoerper, KLK3 antikoerper, Klk1c3 antikoerper, Klkb1 antikoerper, Npepps antikoerper

Hintergrund

Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. KLK 3 (also known as prostate specific antigen) is a marker for prostatic cancer and is involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.

Pathways

Komplementsystem